Article
Loss of <i>Smad4</i> promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation
2021-04-29
Abstract excerpt
Over 85% of lung cancer patients harbor overt or subclinical metastases at diagnosis, and therefore most patients die of progressive metastatic disease despite aggressive local and systemic therapies. Somatic mutations in the Smad4 gene have been found in non-small-cell lung cancer, but the underlying mechanism by which Smad4 loss-of-function (LOF) accelerates lung cancer metastasis is yet to be elucidated. Here,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 942b8ecf-1b3f-5517-b8f3-71bcfe61e1ed
- DOI
- 10.1101/2021.04.29.441956
